Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-17-001399

PRESIDENT, CHIEF STRATEGY OFF. bought 10,000 shares at $3.15 ($31,500)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · PRESIDENT, CHIEF STRATEGY OFF.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-15 Purchase : show line 1 in the form +10,000 $3.15 $31,500 583,241 D
Open-market purchases · 10,000 sh · avg $3.15 · $31,500
Loading xslF345X03/form4-08162017_010858.xml…